A pilot clinical trial to study the effect of ayurvedic medicine in diabetic patient.

â??ANTIDIABETIC ACTIVITY OF HERBOMINERAL FORMULATION (GASY) IN THE MANAGEMENT OF PRAMEHA WITH SPECIAL REFERENCE TO DIABETES MELLITUS- AN EXPERIMENTAL AND PILOT CLINICAL STUDYï¿½? - AADMED

Status

Active, not recruiting

Phases

Phase 2

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2022/04/041951

Enrollment

Registered

2022-04-19

Start date

Unknown

Completion date

Unknown

Last updated

2022-05-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: E119- Type 2 diabetes mellitus without complications

Interventions

None listed

Eligibility

Inclusion criteria

Inclusion criteria: 1) Patient of either gender between the age group of 20 to 70 years of age (both years inclusive) 2) Known cases of Diabetes Mellitus. 3) Patients with FBS 125 mg/dl to 300 mg/dl and PP2BS 140 mg/dl to 400 mg/dl (both inclusive) 4) Patients with HbA1C levels between 7.0 - 12mg%

Exclusion criteria

Exclusion criteria: 1) Patients having FBS more than 300mg/dl and PP2BS more than 400mg/dl, HbA1C more than 12mg% 2) Patients showing acute complications and chronic complications - neuropathy, nephropathy, retinopathy. 3) Lactating and Pregnant Women 4) Uncontrolled hypertension.

Design outcomes

Primary

Measure	Time frame
Assessment on the symptoms of PramehaTimepoint: Effect will be assessed based on the grading of symptoms at baseline and at the end of 30 days till 90 days	—

Secondary

Measure	Time frame
FBS PP2BS HbA1c Serum insulinTimepoint: effect on FBS, PP2BS, HbA1c Serum insulin at baseline and at the end of 30 days till 90 days	—

Countries

India

Contacts

Public ContactDr Smita Chauhan

Parul Institute of Ayurved

drprakash.kc@gmail.com6363202018

Outcome results